These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 9726692)
1. Lack of drug-drug interaction between cerivastatin and nifedipine. Sachse R; Brendel E; Mück W; Rohde G; Ochmann K; Horstmann R; Kuhlmann J Int J Clin Pharmacol Ther; 1998 Aug; 36(8):409-13. PubMed ID: 9726692 [TBL] [Abstract][Full Text] [Related]
2. The effect of omeprazole pre- and cotreatment on cerivastatin absorption and metabolism in man. Sachse R; Ochmann K; Rohde G; Mück W Int J Clin Pharmacol Ther; 1998 Oct; 36(10):517-20. PubMed ID: 9799053 [TBL] [Abstract][Full Text] [Related]
3. Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin. Mazzu AL; Lasseter KC; Shamblen EC; Agarwal V; Lettieri J; Sundaresen P Clin Pharmacol Ther; 2000 Oct; 68(4):391-400. PubMed ID: 11061579 [TBL] [Abstract][Full Text] [Related]
4. Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatin. Mück W; Ritter W; Dietrich H; Frey R; Kuhlmann J Int J Clin Pharmacol Ther; 1997 Jun; 35(6):261-4. PubMed ID: 9208343 [TBL] [Abstract][Full Text] [Related]
5. Absolute and relative bioavailability of the HMG-CoA reductase inhibitor cerivastatin. Mück W; Ritter W; Ochmann K; Unger S; Ahr G; Wingender W; Kuhlmann J Int J Clin Pharmacol Ther; 1997 Jun; 35(6):255-60. PubMed ID: 9208342 [TBL] [Abstract][Full Text] [Related]
6. Influence of erythromycin pre- and co-treatment on single-dose pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatin. Mück W; Ochmann K; Rohde G; Unger S; Kuhlmann J Eur J Clin Pharmacol; 1998 Feb; 53(6):469-73. PubMed ID: 9551706 [TBL] [Abstract][Full Text] [Related]
7. Influence of cholestyramine on the pharmacokinetics of cerivastatin. Mück W; Ritter W; Frey R; Wetzelsberger N; Lücker PW; Kuhlmann J Int J Clin Pharmacol Ther; 1997 Jun; 35(6):250-4. PubMed ID: 9208341 [TBL] [Abstract][Full Text] [Related]
9. Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients. Mück W; Mai I; Fritsche L; Ochmann K; Rohde G; Unger S; Johne A; Bauer S; Budde K; Roots I; Neumayer HH; Kuhlmann J Clin Pharmacol Ther; 1999 Mar; 65(3):251-61. PubMed ID: 10096257 [TBL] [Abstract][Full Text] [Related]
10. The interaction of diltiazem with lovastatin and pravastatin. Azie NE; Brater DC; Becker PA; Jones DR; Hall SD Clin Pharmacol Ther; 1998 Oct; 64(4):369-77. PubMed ID: 9797793 [TBL] [Abstract][Full Text] [Related]
11. Rational assessment of the interaction profile of cerivastatin supports its low propensity for drug interactions. Mück W Drugs; 1998; 56 Suppl 1():15-23; discussion 33. PubMed ID: 9740537 [TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacokinetics of cerivastatin. Mück W Clin Pharmacokinet; 2000 Aug; 39(2):99-116. PubMed ID: 10976657 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic interactions of nifedipine and quinidine. Hippius M; Henschel L; Sigusch H; Tepper J; Brendel E; Hoffmann A Pharmazie; 1995 Sep; 50(9):613-6. PubMed ID: 7480098 [TBL] [Abstract][Full Text] [Related]
14. Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors. Jacobson TA Am J Cardiol; 2004 Nov; 94(9):1140-6. PubMed ID: 15518608 [TBL] [Abstract][Full Text] [Related]
15. Rosiglitazone has no clinically significant effect on nifedipine pharmacokinetics. Harris RZ; Inglis AM; Miller AK; Thompson KA; Finnerty D; Patterson S; Jorkasky DK; Freed MI J Clin Pharmacol; 1999 Nov; 39(11):1189-94. PubMed ID: 10579151 [TBL] [Abstract][Full Text] [Related]
16. Role of small intestinal cytochromes p450 in the bioavailability of oral nifedipine. Zhang QY; Kaminsky LS; Dunbar D; Zhang J; Ding X Drug Metab Dispos; 2007 Sep; 35(9):1617-23. PubMed ID: 17567730 [TBL] [Abstract][Full Text] [Related]
18. Lack of mutual pharmacokinetic interaction between cerivastatin, a new HMG-CoA reductase inhibitor, and digoxin in healthy normocholesterolemic volunteers. Weber P; Lettieri JT; Kaiser L; Mazzu AL Clin Ther; 1999 Sep; 21(9):1563-75. PubMed ID: 10509851 [TBL] [Abstract][Full Text] [Related]